October 20, 2020

Prevalence and Clinical Outcomes of COVID-19 in Patients with Autoimmune Diseases: A Systematic Review and Meta-Analysis

Category: Article Summary

Topic: Clinical Characteristics and Health Care Setting

Keywords (Tags): risk factors

• A meta-analysis of 7 case-control studies show 2.2-fold higher risk of COVID-19 infection among those with autoimmune diseases. Among the 2,766 patients in studies reporting clinical outcomes, use of glucocorticoids and conventional synthetic disease-modifying antirheumatic drugs were associated with increased risk of hospitalization and mortality.

Akiyama et al. (Oct 13, 2020). Prevalence and Clinical Outcomes of COVID-19 in Patients with Autoimmune Diseases: A Systematic Review and Meta-Analysis. Annals of the Rheumatic Diseases. https://doi.org/10.1136/annrheumdis-2020-218946